Aura Timen

3.9k total citations
158 papers, 2.0k citations indexed

About

Aura Timen is a scholar working on Infectious Diseases, Epidemiology and Sociology and Political Science. According to data from OpenAlex, Aura Timen has authored 158 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 69 papers in Infectious Diseases, 50 papers in Epidemiology and 28 papers in Sociology and Political Science. Recurrent topics in Aura Timen's work include Viral Infections and Outbreaks Research (41 papers), Disaster Response and Management (26 papers) and COVID-19 epidemiological studies (25 papers). Aura Timen is often cited by papers focused on Viral Infections and Outbreaks Research (41 papers), Disaster Response and Management (26 papers) and COVID-19 epidemiological studies (25 papers). Aura Timen collaborates with scholars based in Netherlands, United States and Germany. Aura Timen's co-authors include Jim van Steenbergen, Jacco Wallinga, Clementine Wijkmans, Marion Koopmans, Marlies Hulscher, G. Morroy, Corien Swaan, Barbara Schimmer, Susan Hahné and Peter Teunis and has published in prestigious journals such as PLoS ONE, Scientific Reports and Emerging infectious diseases.

In The Last Decade

Aura Timen

134 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Aura Timen Netherlands 23 981 575 336 332 312 158 2.0k
Manoj Murhekar India 30 1.5k 1.5× 634 1.1× 318 0.9× 797 2.4× 378 1.2× 170 2.8k
Jeremy Hawker United Kingdom 26 694 0.7× 742 1.3× 229 0.7× 212 0.6× 205 0.7× 74 2.3k
Bonnie Henry Canada 27 1.7k 1.7× 868 1.5× 563 1.7× 535 1.6× 116 0.4× 74 3.6k
Adam MacNeil United States 31 2.5k 2.5× 742 1.3× 245 0.7× 554 1.7× 152 0.5× 74 3.5k
Anders Tegnell Sweden 23 614 0.6× 682 1.2× 319 0.9× 420 1.3× 124 0.4× 71 2.0k
Richard Heffernan United States 22 659 0.7× 1.6k 2.8× 454 1.4× 408 1.2× 229 0.7× 29 2.6k
Martial L. Ndeffo-Mbah United States 27 1.1k 1.1× 807 1.4× 786 2.3× 658 2.0× 300 1.0× 78 2.5k
Samuel L. Groseclose United States 20 696 0.7× 933 1.6× 115 0.3× 437 1.3× 170 0.5× 31 2.1k
Scott J.N. McNabb United States 24 812 0.8× 840 1.5× 113 0.3× 296 0.9× 203 0.7× 74 1.8k
Joseph Francis Wamala United States 26 1.1k 1.2× 323 0.6× 320 1.0× 361 1.1× 101 0.3× 62 1.9k

Countries citing papers authored by Aura Timen

Since Specialization
Citations

This map shows the geographic impact of Aura Timen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aura Timen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aura Timen more than expected).

Fields of papers citing papers by Aura Timen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aura Timen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aura Timen. The network helps show where Aura Timen may publish in the future.

Co-authorship network of co-authors of Aura Timen

This figure shows the co-authorship network connecting the top 25 collaborators of Aura Timen. A scholar is included among the top collaborators of Aura Timen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aura Timen. Aura Timen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Riccio, Marco Del, Jojanneke van Summeren, Saverio Caini, Koos van der Velden, & Aura Timen. (2025). How Has the Disappearance of Influenza B/Yamagata Altered the Proportion of Influenza A and B Cases? Early Findings From Post‐COVID Pandemic Global Surveillance Data. Influenza and Other Respiratory Viruses. 19(7).
2.
Cuypers, Maarten, et al.. (2025). Cancer screening participation and outcomes among people with an intellectual disability in the Netherlands: a cross-sectional population-based study. The Lancet Public Health. 10(3). e237–e245. 4 indexed citations
4.
Timen, Aura, et al.. (2024). Adaptive organizational network response in a crisis: The case of five European airports during theCOVID‐19 pandemic. Public Administration Review. 84(3). 400–413.
5.
Naaldenberg, Jenneken, et al.. (2024). Cancer risks related to intellectual disabilities: A systematic review. Cancer Medicine. 13(9). e7210–e7210. 9 indexed citations
6.
Stein, Mart L., Alma Tostmann, Jim Duggan, et al.. (2024). A systematic literature review on public health and healthcare resources for pandemic preparedness planning. BMC Public Health. 24(1). 3114–3114. 1 indexed citations
9.
Leensen, M. C. J., Bianca W. M. Schalk, Aura Timen, et al.. (2023). Risk for Severe COVID-19 Outcomes among Persons with Intellectual Disabilities, the Netherlands. Emerging infectious diseases. 29(1). 118–126. 9 indexed citations
11.
Stein, Mart L., Jim van Steenbergen, Rik Crutzen, et al.. (2022). Evaluation of a Web-Based Culturally Sensitive Educational Video to Facilitate Informed Cervical Cancer Screening Decisions Among Turkish- and Moroccan-Dutch Women Aged 30 to 60 Years: Randomized Intervention Study. Journal of Medical Internet Research. 24(10). e35962–e35962. 9 indexed citations
12.
Stein, Mart L., Jim van Steenbergen, Rik Crutzen, et al.. (2021). Decision-making, barriers, and facilitators regarding cervical cancer screening participation among Turkish and Moroccan women in the Netherlands: a focus group study. Ethnicity and Health. 27(5). 1147–1165. 27 indexed citations
13.
Timen, Aura, et al.. (2014). Context analysis for epidemic control in the Netherlands. Health Policy. 119(1). 66–73. 7 indexed citations
14.
Isken, L, Patricia E. Vermeer-de Bondt, H. C. Rümke, et al.. (2013). Implementation of a Q fever vaccination program for high-risk patients in the Netherlands. Vaccine. 31(23). 2617–2622. 30 indexed citations
15.
Keijmel, Stephan P., G. Morroy, Corine Delsing, et al.. (2012). aanhoudende vermoeidheid na een Q-koortsinfectie. Nederlandsch tijdschrift voor geneeskunde/Nederlands tijdschrift voor geneeskunde/NTvG-databank. 156(48). 1 indexed citations
16.
Nabuurs-Franssen, Marrigje H., A. M. Horrevorts, G. Weers-Pothoff, et al.. (2007). Q-Fever outbreak in the Netherlands. Acta Clinica Belgica. 62(6). 452–452. 1 indexed citations
17.
Hahné, Susan, et al.. (2006). Rubella outbreak in the Netherlands: new rubella genotype spread to Canada and led to congenital rubella infections. European Journal of Public Health. 16. 109–109. 1 indexed citations
18.
Wiersma, Tjerk, et al.. (2004). [Tetanus prophylaxis in general practice].. PubMed. 148(44). 2172–3. 3 indexed citations
19.
Timen, Aura, et al.. (2002). Meningitis group C vaccination campaign in the Netherlands. European Journal of Public Health. 12(4). 22–22. 5 indexed citations
20.
Timen, Aura, et al.. (2002). Algemene vaccinatie tegen meningokokken C en pneumokokken; samenvatting van het advies van de Gezondheidsraad. Nederlandsch tijdschrift voor geneeskunde/Nederlands tijdschrift voor geneeskunde/NTvG-databank. 146(33).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026